FIELD: medicine.
SUBSTANCE: claimed is application of 4-methyl-2,6-diisobornylphenol as mediation increasing brain blood flow.
EFFECT: it is demonstrated that effect of 4-methyl-2,6-diisobornylphenol in terms of expression does not yield to effect of vinpocetine, but does not cause reduction of systemic arterial pressure.
2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENTS WITH HEMORHEOLOGICAL, ANTIAGGREGANT AND ANTITROMBOGENIC ACTIVITY | 2007 |
|
RU2347561C2 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
NEUROPROTECTOR | 2009 |
|
RU2406488C1 |
RETINOPROTECTOR | 2009 |
|
RU2406487C1 |
ANTI-ISCHEMIC DRUG | 2012 |
|
RU2499593C1 |
REMEDY HAVING ANTIAGGREGANT ACTIVITY, ACTIVITY DECREASING BLOOD HYPERVISCOSITY AND ANTITHROMBOGENIC ACTIVITY | 2008 |
|
RU2368376C1 |
OSMOTIC DIURETIC POSSESSING ANTITOXIC ACTIVITY IN CASE OF ALIPHATIC ALCOHOL POISONING | 2007 |
|
RU2354390C2 |
AGENT POSSESSING HEMORGHEOLOGICAL AND ANTIPLATELET ACTIVITY | 2007 |
|
RU2342944C1 |
MEANS FOR CEREBRAL BLOOD FLOW INCREASE | 2016 |
|
RU2655810C2 |
MEDICATION FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2014 |
|
RU2555335C9 |
Authors
Dates
2009-04-10—Published
2007-07-10—Filed